Neuroleptic malignant syndrome

From WikiMD's Food, Medicine & Wellnesspedia

Definition[edit | edit source]

Neuroleptic malignant syndrome is a rare neurological condition that is caused by an adverse reaction to neuroleptic (tranquilizer) or antipsychotic drugs. These drugs are commonly prescribed for the treatment of schizophrenia and other neurological, mental, or emotional disorders. The syndrome can also occur in people taking anti-Parkinsonism drugs known as dopaminergics if those drugs are discontinued abruptly.

Cause[edit | edit source]

The exact underlying cause of neuroleptic malignant syndrome is unknown. In some cases, more than one family member can be affected which suggests there may be a genetic component.

Onset[edit | edit source]

In most cases, the disorder develops within the first 2 weeks of treatment with the drug; however, the disorder may develop any time during the therapy period.

Signs and symptoms[edit | edit source]

Symptoms include high fever, sweating, unstable blood pressure, stupor, muscular rigidity, and autonomic dysfunction.

Clinical presentation[edit | edit source]

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.

80%-99% of people have these symptoms

30%-79% of people have these symptoms

5%-29% of people have these symptoms

Diagnosis[edit | edit source]

  • The diagnosis of NMS is based on history and the presence of certain physical examination and laboratory findings.[1].
  • Patients typically develop NMS within hours or days after exposure to a causative drug, with most exhibiting symptoms within 2 weeks and nearly all within 30 days.
  • NMS has classically been characterized by the presence of the triad of fever, muscle rigidity, and altered mental status.

Treatment[edit | edit source]

Prognosis[edit | edit source]

  • Early identification of and treatment for individuals with neuroleptic malignant syndrome improves outcome.
  • If clinically indicated, a low potency neuroleptic can be reintroduced very slowly when the individual recovers, although there is a risk that the syndrome might recur.
  • Another alternative is to substitute another class of drugs for the neuroleptic.
  • Anesthesia may be a risk to individuals who have experienced neuroleptic malignant syndrome.

References[edit | edit source]

  1. Berman B. D. (2011). Neuroleptic malignant syndrome: a review for neurohospitalists. The Neurohospitalist, 1(1), 41–47. https://doi.org/10.1177/1941875210386491


NIH genetic and rare disease info[edit source]

Neuroleptic malignant syndrome is a rare disease.


Neuroleptic malignant syndrome Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.